OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)
Luciana P. Tavares, Eliza Mathias Melo, Lirlândia P. Sousa, et al.
Seminars in Immunology (2022) Vol. 59, pp. 101601-101601
Closed Access | Times Cited: 11

Showing 11 citing articles:

Resolution pharmacology and the treatment of infectious diseases
Vivian Vasconcelos Costa, Filipe Resende, Eliza Mathias Melo, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 7, pp. 917-937
Open Access | Times Cited: 9

The Multifaceted Role of Annexin A1 in Viral Infections
Filipe Resende, Simone de Araújo, Luciana P. Tavares, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1131-1131
Open Access | Times Cited: 8

Angiotensin-(1–7) decreases inflammation and lung damage caused by betacoronavirus infection in mice
Érick Bryan de Sousa Lima, Antônio Felipe Silva Carvalho, Isabella Zaidan, et al.
Inflammation Research (2024)
Closed Access | Times Cited: 2

Crosstalk between the plasminogen/plasmin system and inflammation resolution
Luíza Oliveira Perucci, Juliana P. Vago, Lindsey A. Miles, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 10, pp. 2666-2678
Closed Access | Times Cited: 6

Annexin A1 improves immune responses and control of tissue parasitism during Leishmania amazonensis infection in BALB/c mice
Tiago Queiroga Nery Ricotta, Liliane Martins dos Santos, Laser Antônio Machado Oliveira, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116254-116254
Open Access | Times Cited: 1

Effects of a pro‐resolving drug in COVID‐19: preclinical studies to a randomized, placebo‐controlled, phase Ib/IIa trial in hospitalized patients
Pedro R. J. Almeida, Alexandre M. Periard, Fernanda L. Tana, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 23, pp. 4750-4765
Closed Access | Times Cited: 1

The angiotensin‐(1‐7)/MasR axis improves pneumonia caused by Pseudomonas aeruginosa: Extending the therapeutic window for antibiotic therapy
Isabella Zaidan, Antônio Felipe Silva Carvalho, Laís C. Grossi, et al.
The FASEB Journal (2024) Vol. 38, Iss. 18
Closed Access | Times Cited: 1

Fibrinolysis in COVID-19: Impact on Clot Lysis and Modulation of Inflammation
Lirlândia P. Sousa, Michelle A. Sugimoto, Luíza Oliveira Perucci, et al.
Current Drug Targets (2022) Vol. 23, Iss. 17, pp. 1578-1592
Closed Access | Times Cited: 6

Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases
Mauro Perretti, Manikandan Subramanian
Seminars in Immunology (2022) Vol. 65, pp. 101669-101669
Closed Access | Times Cited: 3

Angiotensin-(1-7) decreases inflammation and lung damage caused by betacoronavirus infection in mice
Érick Bryan de Sousa Lima, Antônio Felipe Silva Carvalho, Isabella Zaidan, et al.
Research Square (Research Square) (2024)
Open Access

Immunopharmacology sessions at the 19th World Congress of Basic & Clinical Pharmacology 2023
Hong Yong Peh, Danila Gurgone, Pasquale Maffia
Pharmacological Research (2023) Vol. 196, pp. 106911-106911
Open Access

Page 1

Scroll to top